| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Net revenue | 26,067 | 29,195 | 21,928 | 21,309 |
| Cost of revenues, exclusive of depreciation and amortization presented separately below | 8,551 | 10,560 | 8,584 | 7,862 |
| Gross profit | 17,516 | 18,635 | 13,344 | 13,447 |
| General and administrative expenses | 14,386 | 14,372 | 14,364 | 13,425 |
| Goodwill impairment | 0 | - | - | 7,489 |
| Depreciation and amortization | 1,080 | 1,074 | 1,094 | 1,095 |
| Total operating expenses | 15,466 | 15,446 | 15,458 | 22,009 |
| Income (loss) from operations | 2,050 | 3,189 | -2,114 | -8,562 |
| Interest expense | 1,154 | 1,603 | 1,297 | 1,524 |
| Other income | 62 | 37 | 39 | 38 |
| Interest income | 91 | 90 | 88 | 107 |
| Total other expenses, net | -1,001 | -1,476 | -1,170 | -1,379 |
| Income (loss) before provision for income taxes | 1,049 | 1,713 | -3,284 | -9,941 |
| Income tax benefit (expense) | 270 | 181 | -1,085 | -817 |
| Net income (loss) | 779 | 1,532 | -2,199 | -9,124 |
| Income (loss) per share basic (in dollars per share) | 0.04 | 0.08 | -0.12 | -0.5 |
| Income (loss) per share diluted (in dollars per share) | 0.04 | 0.08 | -0.12 | -0.5 |
| Weighted average number of shares outstanding basic (in shares) | 18,576,199 | 18,510,834 | 18,470,808 | 18,323,542 |
| Weighted average number of shares outstanding diluted (in shares) | 19,459,877 | 19,015,496 | 18,470,808 | 18,323,542 |
OptimizeRx Corp (OPRX)
OptimizeRx Corp (OPRX)